JPMorgan Keeps Neutral on EMR but Raises Target Ahead of Q4 Earnings

Emerson Electric Co. (NYSE:EMR) is included among the 13 Best Dividend Kings to Buy in 2026.

On January 16, JPMorgan analyst Stephen Tusa raised JPMorgan’s price target on Emerson Electric Co. (NYSE:EMR) to $157 from $150, while keeping a Neutral rating on the stock. The change was part of the bank’s broader Q4 earnings preview for the electrical equipment and multi-industry space, where it updated a range of ratings and targets. JPMorgan said it is leaning more favorably toward “growth related names into and out of the quarter.”

That comes as Emerson continues working through a mixed demand environment. Back in November, the company reported fourth-quarter revenue that came in below expectations, with demand for its automation equipment remaining uneven. Emerson has spent the last few years reshaping itself into a more automation-focused business, but the transition has not been completely smooth. The company is still trying to build stronger momentum in the unit, and margins have not ramped up as much as investors have wanted.

To position itself for longer-term automation demand, Emerson has also been active on the deal front, streamlining its portfolio and investing heavily in areas it believes will drive growth. One of the biggest moves was last year’s agreement to buy the remainder of AspenTech that it did not already own, valuing the deal at roughly $15.1 billion.

Even with automation demand moving in fits and starts, not all parts of the business have been under pressure. Emerson’s measurement and analytical devices segment has continued to hold up well, supported by steady demand from customers across chemical, oil, and gas markets.

Emerson Electric Co. (NYSE:EMR) is a global technology and software company that provides solutions to customers across a wide range of industries around the world.

While we acknowledge the potential of EMR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Dividend Growth Stocks with the Highest Growth Rates and 14 Best Mid Cap Dividend Aristocrat Stocks to Buy Now

Disclosure: None.